News
03-27-2012, 03:50 AM
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the fourth quarter and full year ended December 31, 2011.
More... (http://www.news-medical.net/news/20120327/Vermillion-fourth-quarter-total-revenues-increase-15225-to-24868000.aspx)
More... (http://www.news-medical.net/news/20120327/Vermillion-fourth-quarter-total-revenues-increase-15225-to-24868000.aspx)